| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |